Personal tools
You are here: Home → The Cancer Letter Archive → March 12, 2010, Vol. 36 No. 9
Navigation
Subscribe to our mailing list
for product news and updates


 
Document Actions

March 12, 2010, Vol. 36 No. 9

by Kirsten Goldberg — last modified 2010-03-12 16:53

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network. NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions. St. Martin's Press Buys Rights To Book By Brawley, Goldberg. Collins, Lander, Botstein Win Albany Prize.

Welcome. Please log in to download the newsletter if you are a subscriber. You can use the log in box in the right column. If not a subscriber, please subscribe or get a one day pass using the links below.


Click here to subscribe

Click here to get a one day pass

Log in


Forgot your password?
Google Ad Links
Google Ads
 
Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: